查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2049342

非侵入性產前檢測市場報告：按產品類型、檢測類型、技術、方法、應用、最終用戶和地區分類（2026-2034 年）

Non-Invasive Prenatal Testing Market Report by Product Type, Test Type, Technology, Method, Application, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球非侵入性產前檢測（NIPT）市場規模達52億美元。展望未來，IMARC Group預測，該市場從2026年到2034年將以13.30%的複合年成長率成長，到2034年達到164億美元。

非侵入式產前檢測 (NIPT) 是一種產前篩檢方法，它透過採集孕婦的血液樣本來檢測胎兒是否有異常。此檢測主要用於診斷唐氏症（21三體症）、愛德華氏症候群（18三體症）、巴陶氏症（13三體症）和透納氏症遺傳性疾病，其原理是透過分析母親血液中的DNA片段。 NIPT 無需進行絨毛膜取樣 (CVS) 等有風險的侵入性操作，並且可以從懷孕第9週開始進行。

胎兒遺傳疾病盛行率的不斷上升是市場成長的主要促進因素之一。此外，生命科學和醫療保健產業的科技進步也在推動市場發展。例如， DNA測序技術、再生醫學以及分子研究的突破性進展，為早期預防嚴重疾病風險創造了巨大的潛力。此外，產前檢測率的提高，以及公眾健康意識的增強和對產前檢測益處及重要性的認知不斷加深，也推動了市場成長。醫護人員和孕婦正在採用替代方法，在胎兒發育早期診斷和治療其他遺傳疾病，例如脊柱裂、顎裂和鐮狀細胞貧血。此外，高齡生產（35歲及以上）趨勢的變化也對市場成長產生正面影響。高齡產婦可能導致多種健康併發症，包括高血壓風險增加、生育能力下降、流產和胎兒染色體異常。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球無創產前檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 消耗品
  • 裝置

第7章 市場區隔：依測試類型分類

  • Materni 21
  • Harmony
  • 全景
  • Verifi
  • NIFTY
  • 其他

第8章 市場區隔：依技術分類

  • NGS
  • WGS
  • 其他

第9章 市場區隔：依方法

  • 超音波檢測
  • 生化篩檢試驗
  • 母體血漿中的無細胞DNA檢測
  • 母體血液中胎兒細胞檢測
  • 其他

第10章 市場區隔：依應用領域分類

  • 三體症候群
  • 微缺失症候群
  • 其他

第11章 市場區隔：依最終用戶分類

  • 醫院
  • 診斷檢查室
  • 其他

第12章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第13章 SWOT 分析

第14章：價值鏈分析

第15章：波特五力分析

第16章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Berry Genomics
    • BGI
    • CENTOGENE GmbH
    • Eurofins LifeCodexx GmbH
    • F. Hoffmann-La Roche Ltd
    • Igenomix
    • Illumina, Inc.
    • Laboratory Corporation of America Holdings
    • MedGenome
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific Inc.
    • Yourgene Health
Product Code: SR112026A2086

The global non-invasive prenatal testing market size reached USD 5.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 16.4 Billion by 2034, exhibiting a growth rate (CAGR) of 13.30% during 2026-2034.

Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman's blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother's blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.

The growing prevalence of genetic disorders of the fetus is one of the key factors driving the market growth. Furthermore, technological advancements in the field of life sciences and healthcare industry is also providing a boost to the market. For instance, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have created immense possibilities to combat the chances of any serious disease at the primitive stage itself. Additionally, the increasing acceptance rate for prenatal testing, along with rising health consciousness and awareness regarding the benefits and significance of such testing among the masses, is also driving the market growth. Healthcare providers, as well as expecting parents, are adopting alternatives to diagnose other genetic disorders, including spina bifida, cleft palate, and sickle cell anemia, and treat them in the early stages of fetal development. Moreover, the shifting trend toward childbearing at high maternal age (35 years or older) is also positively impacting the market growth. Advancing maternal age can lead to numerous health complications, such as high blood pressure, reduced fertility, risk of miscarriage and increased risk of chromosomal anomalies in the fetus.

KEY MARKET SEGMENTATION :

Breakup by Product Type:

  • Consumables
  • Instruments

Breakup by Test Type:

  • Materni 21
  • Harmony
  • Panaroma
  • Verifi
  • NIFTY
  • Others

Breakup by Technology:

  • NGS
  • WGS
  • Others

Breakup by Method:

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-Free DNA in Maternal Plasma Tests
  • Fetal Cells in Maternal Blood Tests
  • Others

Breakup by Application:

  • Trisomy
  • Microdeletion Syndrome
  • Others

Breakup by End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report provides a comprehensive analysis of the competitive landscape in the global non-invasive prenatal testing market with detailed profiles of all major companies, including:

  • Berry Genomics
  • BGI
  • CENTOGENE GmbH
  • Eurofins LifeCodexx GmbH
  • F. Hoffmann-La Roche Ltd
  • Igenomix
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • MedGenome
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.
  • Yourgene Health

Key Questions Answered in This Report

1. What was the size of the global non-invasive prenatal testing market in 2025?

2. What is the expected growth rate of the global non-invasive prenatal testing market during 2026-2034?

3. What are the key factors driving the global non-invasive prenatal testing market?

4. What has been the impact of COVID-19 on the global non-invasive prenatal testing market?

5. What is the breakup of the global non-invasive prenatal testing market based on the product type?

6. What is the breakup of the global non-invasive prenatal testing market based on the test type?

7. What is the breakup of the global non-invasive prenatal testing market based on the technology?

8. What is the breakup of the global non-invasive prenatal testing market based on the method?

9. What is the breakup of the global non-invasive prenatal testing market based on the application?

10. What is the breakup of the global non-invasive prenatal testing market based on the end-user?

11. What are the key regions in the global non-invasive prenatal testing market?

12. Who are the key companies/players in the global non-invasive prenatal testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Non-Invasive Prenatal Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Materni 21
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Harmony
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Panaroma
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Verifi
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 NIFTY
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 NGS
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 WGS
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Method

  • 9.1 Ultrasound Detection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Screening Tests
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cell-Free DNA in Maternal Plasma Tests
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Fetal Cells in Maternal Blood Tests
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Trisomy
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Microdeletion Syndrome
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by End-User

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Diagnostic Laboratories
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Berry Genomics
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 BGI
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 CENTOGENE GmbH
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Eurofins LifeCodexx GmbH
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 F. Hoffmann-La Roche Ltd
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 SWOT Analysis
    • 16.3.6 Igenomix
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Illumina, Inc.
      • 16.3.7.1 Company. Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Laboratory Corporation of America Holdings
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 MedGenome
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Myriad Genetics, Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Natera, Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Quest Diagnostics Incorporated
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis
    • 16.3.14 Yourgene Health
      • 16.3.14.1 Company Overview
      • 16.3.14.2 Product Portfolio
      • 16.3.14.3 Financials

List of Figures

  • Figure 1: Global: Non-Invasive Prenatal Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Non-Invasive Prenatal Testing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Non-Invasive Prenatal Testing Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Non-Invasive Prenatal Testing Market: Breakup by Test Type (in %), 2025
  • Figure 5: Global: Non-Invasive Prenatal Testing Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Non-Invasive Prenatal Testing Market: Breakup by Method (in %), 2025
  • Figure 7: Global: Non-Invasive Prenatal Testing Market: Breakup by Application (in %), 2025
  • Figure 8: Global: Non-Invasive Prenatal Testing Market: Breakup by End-User (in %), 2025
  • Figure 9: Global: Non-Invasive Prenatal Testing Market: Breakup by Region (in %), 2025
  • Figure 10: Global: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 11: Global: Non-Invasive Prenatal Testing (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Non-Invasive Prenatal Testing (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Non-Invasive Prenatal Testing (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Non-Invasive Prenatal Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Non-Invasive Prenatal Testing (Materni 21) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Non-Invasive Prenatal Testing (Materni 21) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Non-Invasive Prenatal Testing (Harmony) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Non-Invasive Prenatal Testing (Harmony) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Non-Invasive Prenatal Testing (Panaroma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Non-Invasive Prenatal Testing (Panaroma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Non-Invasive Prenatal Testing (Verifi) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Non-Invasive Prenatal Testing (Verifi) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Non-Invasive Prenatal Testing (NIFTY) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Non-Invasive Prenatal Testing (NIFTY) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Non-Invasive Prenatal Testing (NGS) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Non-Invasive Prenatal Testing (NGS) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Non-Invasive Prenatal Testing (WGS) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Non-Invasive Prenatal Testing (WGS) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Non-Invasive Prenatal Testing (Trisomy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Non-Invasive Prenatal Testing (Trisomy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Global: Non-Invasive Prenatal Testing (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Global: Non-Invasive Prenatal Testing (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: North America: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: North America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: United States: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: United States: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Canada: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Canada: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Asia Pacific: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Asia Pacific: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: China: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: China: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Japan: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Japan: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: India: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: India: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: South Korea: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: South Korea: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Australia: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Australia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Indonesia: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Indonesia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Europe: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Europe: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Germany: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Germany: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: France: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: France: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: United Kingdom: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: United Kingdom: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Italy: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Italy: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Spain: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Spain: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Russia: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Russia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Latin America: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Latin America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Brazil: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 96: Brazil: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 97: Mexico: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 98: Mexico: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 99: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 100: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 101: Middle East and Africa: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 102: Middle East and Africa: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 103: Global: Non-Invasive Prenatal Testing Industry: SWOT Analysis
  • Figure 104: Global: Non-Invasive Prenatal Testing Industry: Value Chain Analysis
  • Figure 105: Global: Non-Invasive Prenatal Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Non-Invasive Prenatal Testing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 4: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 5: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Method (in Million USD), 2026-2034
  • Table 6: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 7: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 8: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 9: Global: Non-Invasive Prenatal Testing Market Structure
  • Table 10: Global: Non-Invasive Prenatal Testing Market: Key Players